The DOI matches its Crossref record; 122 of the 125 references it cites were found in a registry or an index.
IL-6 pathway in the liver: From physiopathology to therapy
Open accessAbstract
Interleukin 6 (IL-6) is a pleiotropic four-helix-bundle cytokine that exerts multiple functions in the body. In the liver, IL-6 is an important inducer of the acute phase response and infection defense. IL-6 is furthermore crucial for hepatocyte homeostasis and is a potent hepatocyte mitogen. It is not only implicated in liver regeneration, but also in metabolic function of the liver. However, persistent activation of the IL-6 signaling pathway is detrimental to the liver and might ultimately result in the development of liver tumors. On target cells IL-6 can bind to the signal transducing subunit gp130 either in complex with the membrane-bound or with the soluble IL-6 receptor to induce intracellular signaling. In this review we describe how these different pathways are involved in the physiology and pathophyiology of the liver. We furthermore discuss how IL-6 pathways can be selectively inhibited and therapeutically exploited for the treatment of liver pathologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interleukin-6 (IL-6) plays an important role in both the acute-phase response against infections as well as liver regeneration (Figure 1).”
From The Role of Perioperative Interleukin-6 Serum Levels on Liver Dysfunction and Infectious Complications After Hepatectomy—A Systematic Review (2025) · cites this paper as [2]
In the citing paper
“As a pro-inflammatory cytokine IL-6 is produced at local tissue sites by various cells [1,2].”
From The Role of Perioperative Interleukin-6 Serum Levels on Liver Dysfunction and Infectious Complications After Hepatectomy—A Systematic Review (2025) · cites this paper as [2]
In the citing paper
“Moreover, IL-6 is a major factor in hepatic regeneration [2].”
From The Role of Perioperative Interleukin-6 Serum Levels on Liver Dysfunction and Infectious Complications After Hepatectomy—A Systematic Review (2025) · cites this paper as [2]
In the citing paper
“The acute phase response in the liver usually does not exceed 48 h, after which the organism returns to normal hepatic function, except in chronic states of inflammation [2].”
From The Role of Perioperative Interleukin-6 Serum Levels on Liver Dysfunction and Infectious Complications After Hepatectomy—A Systematic Review (2025) · cites this paper as [2]
In the citing paper
“However, the deletion of il6 gene also impairs the hepatocyte homeostasis and liver regeneration [3–5].”
From The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases (2024) · cites this paper as [5]
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Obesity and the Metabolic Syndrome in Children and Adolescents
Weiss, R., Dziura, J., Burgert, T. S., Tamborlane, W. V., Taksali, S. E., Yeckel, C. W., Allen, K., Lopes, M., Savoye, M., Morrison, J. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031049 · Cited by 3,495
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Pedersen, B. K., & Febbraio, M. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.49 · Cited by 2,909
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,907
Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben‐Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,423
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
Flagged first, then by citations
3 of the 125 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 801–878 of 878
Eskander, A. E., Rady, H. I., Balah, M. M., et al. (2025) · Egyptian Pediatric Association Gazette · doi:10.1186/s43054-025-00391-6
Metabolic Disorders in Mice Bearing Transplantable Hepatoma 22a: a Focus on Ceruloplasmin
Zelenskyi, Е. А., Rutto, K. V., Trulioff, A. S., et al. (2025) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093025030172
“The acute-phase response is the body’s reaction to tissue damage, which typically develops within the first 24–48 h [23].”
Hsieh, M.-W., Chen, H.-Y., & Tsai, C. (2025) · Indian Journal of Microbiology · doi:10.1007/s12088-025-01506-8
“Activated bone marrow cells also release inflammatory cytokines (IL-1 and TNF-α ), triggering the production and secretion of IL-6 in large quantities by other cells, including endothelial cells and fibroblasts, thus establishing positive feedforward control [33].”
Akıncı, M., YAKUT, Z. A. Ç., Bakar, E., & Oltulu, Ç. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04458-4
“Furthermore, being a powerful hepatocyte mitogen, IL-6 is crucial for the liver’s metabolic processes (Schmidt-Arras and Rose-John 2016).”
MELATONIN: A FORGOTTEN MOLECULE TO PROTECT AGAINST SARS-COV-2 MEDIATED CARDIO-RESPIRATORY DISORDER
Ghosh, A., BANERJEE, S., DEBNATH, S., & Ghosh, A. (2025) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2025v17i8.54583
Zhou, J., & Peng, Y. (2025) · Springer eBooks · doi:10.1007/978-981-96-7364-3_1
Sánchez-Guerrero, G., Chavez, D. K., Jaeschke, H., & Ramachandran, A. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70448
Ling, J., Zhou, Q., Xie, F., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1607101
“IL-6 plays a pivotal role in stimulating hepatic synthesis of acute-phase proteins, including C3 and C4 (21, 22).”
Turčić, M., & Pavelić, S. K. (2025) · Science, Art and Religion. · doi:10.5005/jp-journals-11005-0108
Shinsato, R. N., & Herai, R. H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.15.676285
Larrey, D. G., Zhou, F. L., Brulle-Wohlhueter, C., Bénamor, M., Chavin, J. M., Razaz, N., Bejuit, R., Dauriat, J., Reppelin, T., Péan, R., et al. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106785
Gunadi, J. W., Jasaputra, D. K., Jonathan, W., Lesmana, R., Christoper, A., & Zulhendri, F. (2025) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v9i10.19
González‐Corralejo, C., García‐Sáez, J., Figueroa‐Fuentes, M., Addante, A., Roncero, C., Lazcanoiturburu, N., Pacheco, B., Sanz, J., Gato, C., Fernández‐Calderón, E., et al. (2025) · FEBS Journal · doi:10.1111/febs.70315
“In fact, IL6 and STAT3 have proved essential for hepatocyte proliferation, while AKT is commonly associated with cell survival, besides other functions [22,23].”
Deng, D., Lin, S., Liu, Q., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149243
Zheng, L., Zhang, X., Feng, H., Guo, J., & Yu, Z. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104566
Wang, X., Hu, Y.-H., Luo, J.-J., & Wang, Y. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.103260
Zhao, Z., Song, J., Tang, B., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13285234
Hany, N. M., Eissa, S., Basyouni, M., Hasanin, A. H., Aboul-Ela, Y. M., Magd, N. M. A. E., Montasser, I. F., Ali, M. A., Skipp, P. J. S., & Matboli, M. (2022) · Figshare · doi:10.6084/m9.figshare.20408668
Xu, Y., Zhu, Y., Wu, Z., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24202621
Català-Senent, J. F., Hidalgo, M. R., Berenguer, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14314390
Zhao, Y., Cui, L., Yang, X. X., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17056876
Zhao, Z., Song, J., Tang, B., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13285237
Català-Senent, J. F., Hidalgo, M. R., Berenguer, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14314393
Català-Senent, J. F., Hidalgo, M. R., Berenguer, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14314396
Li, X., Wang, Z., Jiao, C., Zhang, Y., Xia, N. L., Yu, W., Chen, X., Wikana, L. P., Liu, Y., Sun, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26568550
Català-Senent, J. F., Hidalgo, M. R., Berenguer, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14314402
Li, X., Wang, Z., Jiao, C., Zhang, Y., Xia, N., Yu, W., Chen, X., Wikana, L. P., Liu, Y., Sun, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26568547
Català-Senent, J. F., Hidalgo, M. R., Berenguer, M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14314405
Zhou, Y.-Y. (2025) · New discovery. · doi:10.61958/quba7215
Каминный, А. И., Shuvalova, Y. A., Kaminnaya, V. I., & Палеев, Ф. Н. (2025) · Russian Cardiology Bulletin · doi:10.17116/cardiobulletin2025200415
Cheng, L., Guo, C., & Yang, Y. (2026) · European journal of medical research · doi:10.1186/s40001-025-03791-x
“This process is interrelated to activation of DNA repair enzymes (such as Neile-1, 8-oxodGTPase, OGG1, APEX1, and UDG etc.) and is conducive to accurately replicating and restoring liver quality [19].”
Mechanisms of Liver Regeneration
Kofler, A., Poelsler, L. H., Oberhuber, R., & Primavesi, F. (2026) · Springer eBooks · doi:10.1007/978-3-032-10997-2_1
Zou, M., Yang, S., Feng, J., & Yang, Z. (2026) · Annals of Hepatology · doi:10.1016/j.aohep.2026.102195
Asaga, P. M., Ibeh, D. C., Ramalan, M. A., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1789692
“Interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-a ) are pro-in fl ammatory mediators implicated in hepatic fi brosis, whilst interferon-gamma (IFN-g ) is essential for non-cytolytic viral clearance (11, 12).”
Lee, J. H., Jeong, W. K., Kim, J. M., Choi, G., Rhu, J., & Cha, D. I. (2026) · European Radiology · doi:10.1007/s00330-026-12435-5
“Interleukin-6, released by muscle fi bers [32], plays a pivotal role in liver regeneration, with a pronounced increase observed after hepatectomy [33].”
Karmakar, S., Mukherjee, U., Ghosh, S., Samanta, A., & Maitra, S. (2026) · Journal of Hazardous Materials Advances · doi:10.1016/j.hazadv.2026.101119
Najem, H. F., Al-Sugmiany, R. Z., & Zeidan, M. M. (2026) · AIP conference proceedings · doi:10.1063/5.0318744
Silva, F. D. (2018) · theses.fr (ABES) · doi:10.70675/a1ef7558z4d24z4e76zb646zb00718717192
Guilcher, C. L. (2018) · theses.fr (ABES) · doi:10.70675/31755573zc52bz4020zb736za39dcd3e9230
IL - 17 et réponse inflammatoire systémique : focus sur le foie et le muscle
Beringer, A. (2018) · theses.fr (ABES) · doi:10.70675/2d9a348ez5879z4d92z938fz1e4047d398bc
Protective effect of selenium against CCl4-induced liver fibrosis via GSH/TGF-β1/caspase-3 pathway
Elsheikh, A., Amer, M., Amer, M., Othman, A., & El-Missiry, M. A. (2025) · Egyptian Journal of Basic and Applied Sciences · doi:10.1080/2314808x.2026.2654913
“It is reported that IL-6 plays a significant role in liver fibrosis based on its ability to upregulate hepatic inflammation and collagen formation, including type I collagen, which is produced via ECM components as a result of HSC activation [39].”
Rôle de Programmed cell Death-Ligand 1 dans la progression du carcinome hépatocellulaire
Rousseau, B. (2021) · theses.fr (ABES) · doi:10.70675/dd181429zd664z4681zbe04z06271b5e1f39
Rôle des cellules de Kupffer dans la physiopathologie des hépatites aiguës
Chabat-Courrède, C. (2024) · theses.fr (ABES) · doi:10.70675/68752933z5f36z44e9z866az70f7363a7e98
Lévêque, C. (2024) · theses.fr (ABES) · doi:10.70675/0d961065ze6e6z464fz8e74zd9c653b2325f
Shen, Y., Zhou, D., Wei, T., et al. (2026) · Aquatic Toxicology · doi:10.1016/j.aquatox.2026.107825
Moura, M. J., Chatterjee, A., Wali, S., Garza, D. M., Salim, H., Rong, J., Menon, R., Jafri, F. I., Rivera, A. C. U., Mortan, R. E., et al. (2026) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2026.2659253
“…in IMH [2–5, 65, 78, Tocilizumab, an IL-6 receptor antagonist, has demonstrated potential in small case series as a third-line treatment for steroid-and mycophenolate-refractory immune-mediated hepatitis, with some reports noting rapid biochemical improvement after one or two infusions [84–86].”
Potential Therapy for Long COVID and Post-vaccination Syndrome
Turčić, M., Pavelić, S. K., & Pavelić, K. (2026) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-032-06531-5_41
Sheng, Y., Liu, Z., Yang, Y., et al. (2026) · Chinese Journal of Analytical Chemistry · doi:10.1016/j.cjac.2026.100743
Chen, L., Wang, Y., Liu, S., Huo, G., Yang, Y., Xu, N., Wang, H., Zhao, H., Zhang, Z., Fu, R., et al. (2026) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/cjgh/7390933
Deng, F., Chen, R., Luo, W., Liu, J.-G., Yang, G., Ma, L., & Zhang, T. (2026) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2026.2679608
“…signaling pathway (Dajani et al. 2007); il-6 exacerbates the local inflammatory microenvironment by promoting the release of acute-phase proteins (schmidt-arras and Rose-John 2016); iFN-γ enhances immune attack effects by activating macrophages and natural killer (NK) cells, and it works…”
Amemiya, T., & Suzuki, H. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05558-5
“IL-6 binds to IL-6 receptors expressed on the surface of hepatocytes and activates intracellular signaling, thereby promoting CRP synthesis, an acute-phase protein that functions as an inflammatory biomarker (Schmidt-Arras and Rose-John 2016).”
tVNS Mitigates Neuroinflammation and Nociception in a Rodent LPS Endotoxemia Model
Atalar, K., Alim, E., Çalıkuşu, A., Topa, E., Dağıdır, H. G., Bahçelioğlu, M., Bukan, N. C., Erten, F., Sahin, K., Dizakar, S. Ö. A., et al. (2026) · Clinical and Translational Science · doi:10.1111/cts.70633
“While traditionally recognized as a pro-inflammatory agent, it also exerts significant anti-inflammatory and regulatory effects by promoting M2 macrophage polarization under certain conditions [41].”
Progress in immune-modulating biomaterials for complement system regulation
Abudousu, A., Tang, Y., Xiang, L., Wang, Z., Li, Y., Zhao, D., Mutailifu, M., Jiang, Q., Liu, B., & Cui, W. (2026) · Progress in Materials Science · doi:10.1016/j.pmatsci.2026.101765
Yamasaki, K., & Kuriyama, I. (2026) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbag093
Huang, C., Yin, M., Liu, H., Jia, W., Niu, L., & Jia, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1848121
The liver-brain axis, from its function to preventive therapeutic strategies in diseases
Chen, Y., Xu, S., & Sun, T. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1858091 · Cited by 1
Yi, X., Meng, C., Zhang, H., Lu, Q., Zhang, K., Li, X., Huang, H., Jiang, J., Lin, Y., Xing, M., et al. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.06.030
Wang, X., Song, W., Zhang, X., Li, Y., Sun, R., & Sun, Z. X. (2026) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2026.103603
Liver fibrosis: Pathogenesis and innovative nanoparticle-based therapeutic strategies
Cai, Y., Li, J., Chen, S., Zhang, H., Tan, J., Li, H., Zhang, S., Li, B., Wei, Q., Lin, C., et al. (2026) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2026.100596
Overexpression of human interleukin 6 in NaCl inducible bacterial system and its characterization
Chakole, V. R., & Sen, P. (2026) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-026-05803-w
Sicklinger, F., Thiemann, T., Rupprecht, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.07.736969
“IL-6 is a key cytokine produced by myeloid cells under inflammatory conditions ( 21 ), yet other cell types and organs including the liver represent established sources under certain pathological conditions ( 22, 23 ).”
Zeng, R., Wang, M., Wang, K., Xing, Z., Hong, Y., Li, T., Zong, G., Yang, C., Zhang, D. H., Chen, Z., et al. (2026) · Advanced Science · doi:10.1002/advs.76416 · Cited by 1
“Depression has been associated with elevated circulating inflammatory cytokines, particularly interleukin-6 (IL-6), a canonical activator of JAK-STAT signaling [ 53–55 ].”
The role of interleukin-6 receptor in cardiovascular and cerebrovascular diseases
Zou, J., Wang, Z., Jiang, M., Yang, Y., Liu, R., Wu, J., Li, H., Wang, Y., & Cheng, S. (2026) · The Innovation Medicine · doi:10.59717/j.xinn-med.2026.100239
Karlsson, W. K., Christensen, R. H., Al‐Khazali, H. M., Olsen, D. A., Madsen, J. S., Ashina, M., & Ashina, H. (2026) · European Journal of Neurology · doi:10.1111/ene.70714
Nicotinamide N-methyltransferase couples inflammation and epigenetic remodeling to hepatic fibrosisPreprint
Sukhanava, S., Allo, P. V., He, Y., Chen, L., Zhu, Y., Youhanna, S. C., García‐Irigoyen, O., Li, Q., Ellis, E., Lauschke, V. M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.30.740978
“Among the inflammatory cytokines implicated in MASLD progression, interleukin-1β (IL-1β) (5, 6), interleukin-6 (IL-6) (7, 8), and tumor necrosis factor-α (TNFα) (9) are consistently elevated in patients with steatohepatitis and advanced fibrosis.”
Kim, T., Hong, H. J., Choi, J., Lee, H. J., & Koh, W. (2026) · Small · doi:10.1002/smll.75002
Qian, K., Xue, Y., & Shi, X. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1861087
Birzer, A., Draßner, C., Muehl-Zuerbes, P., Kuhnt, C., Krawczyk, A., Thoma‐Kress, A. K., Steinkasserer, A., & Popella, L. (2026) · Journal of General Virology · doi:10.1099/jgv.0.002280
Trives-Folguera, L., Muñoz‐Fernández, S., Esteban-Ortega, M. D. M., et al. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1917539
“Experimental studies in murine models have shown that IL-6 deficiency leads to an attenuated acute-phase response following inflammatory stimuli, under-scoring its central role in hepatic APR induction (7).”
InfluentialExerkines in precision management of metabolic diseases
Jin, L., Lin, Y., Zheng, Y., Wang, A., Liao, P., Luo, Y., Sui, Z., Ni, X., Zhang, J., Shen, Q., et al. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004200
Comprehensive review of post-hepatectomy liver failure: definition, prediction, and intervention
Maimaiti, M., Azhati, Y., Mamuti, A., Zhang, Y., Wu, J., Tulading, A., Abudukadi, G., Wang, M., Zeng, H., Keranmu, G., et al. (2026) · International Journal of Surgery · doi:10.1097/js9.0000000000005272
MiR-122 regulates liver tolerance
Gefen, M., Layani, S., Klahr, E., Shemuelian, Z., Brandi, J., Jacobs, T., Steeg, C., Adlung, L., Kilian, C., Ordan, M., et al. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.102020
Self-citationTang, D., Wu, Y.-N., Ding, L., Ding, X.-L., Chen, J., Sun, Y.-T., Guo, J.-J., Lu, L.-J., & Wang, R.-Y. (2026) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2026.08.006
CARVALHO, R. D. S., Marsili, D. E. M. F., Nascimento, B. D. S., et al. (2026) · Small Ruminant Research · doi:10.1016/j.smallrumres.2026.107905
Mehmetbeyoğlu, E., Sancak, S., Abusalim, M. R. S., KAÇAMAK, P., Aktaş, S., Doğanyiğit, Z., & Taheri, S. (2026) · Uludağ Üniversitesi Tıp Fakültesi Dergisi · doi:10.32708/uutfd.1964679
Yu, X., Ma, H., Wang, C., Feng, K., Sun, P., Zhang, J., Lu, J., Zhang, H., Wang, C., Wang, C., et al. (2026) · Biology · doi:10.3390/biology15191725
Abudouleh, E., Elsayim, R., Alhamdi, H. W. S., Almebairik, N. F., & Alkubaisi, N. A. O. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198915
Metadata
- Authors
- Schmidt-Arras, D., & Rose-John, S.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 64
- Issue
- 6
- Pages
- 1403-1415
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2253819322
- Semantic Scholar
- 475d5a2af141aef15b1a1a8fb6b45473f2ce0e4b
- Cited by
- 881
- References
- 125
- Citations by year
- 2026: 59 · 2025: 106 · 2024: 97 · 2023: 106 · 2022: 121 · 2021: 114 · 2020: 98 · 2019: 72 · 2018: 54 · 2017: 37 · 2016: 17
- FWCI
- 27.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Hepatology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Keywords
- interleukin-6, IL-6 signaling, liver, acute phase response, liver regeneration, hepatic metabolism, gp130, soluble IL-6 receptor, IL-6 inhibition, liver disease treatment, liver tumors
- MeSH terms
- Interleukin-6 Inhibitors, Acute-Phase Reaction, Animals, Humans, Insulin Resistance, Liver, Liver Neoplasms, Liver Regeneration, Signal Transduction, Interleukin-6, Receptors, Interleukin-6, STAT3 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
